VOR BIOPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.69 USD | -0.59% |
|
-1.17% | -24.89% |
| 03-21 | Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating | MT |
| 03-21 | Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating | MT |
Chart calendar Vor Biopharma Inc.
77c35840433d6858fd4643101e20913e.n0venGdt_lVT-oMOHtFYE_efXgHywIV3RP4TdaUn-1g._R-k0iNfnBgeuOpeW50NS7jNFECer_BaCpBSEP9umADTfeesLD-3HD2z5A~49de4cb3be1c589eaadf24a8cfd00042
Upcoming events on Vor Biopharma Inc.
Past events on Vor Biopharma Inc.
| 09/04/2024 20:45 | Needham Healthcare Conference |
| 26/03/2024 18:30 | H.C. Wainwright Cell Therapy Virtual Conference |
| 20/03/2024 20:05 | Q4 2023 Earnings Release |
| 12/03/2024 20:35 | Barclays Global Healthcare Conference |
| 14/02/2024 15:00 | Oppenheimer Healthcare Life Sciences Conference |
| 12/12/2023 02:00 | American Society of Hematology Meeting |
| 11/12/2023 19:00 | American Society of Hematology Meeting |
| 11/12/2023 02:00 | American Society of Hematology Meeting |
| 10/12/2023 18:00 | American Society of Hematology Meeting |
| 09/12/2023 22:15 | American Society of Hematology Meeting |
| 05/12/2023 18:30 | JMP Securities Hematology and Oncology Summit |
| 30/11/2023 19:00 | Piper Sandler Healthcare Conference - Fireside Chat |
| 29/11/2023 20:00 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 14/11/2023 20:35 | Stifel Healthcare Conference - Fireside Chat |
| 11/11/2023 00:15 | ASTCT EBMT International Conference |
| 09/11/2023 21:30 | Business Update Call |
| 07/11/2023 21:05 | Q3 2023 Earnings Release |
| 02/11/2023 13:30 | Business Update Call |
| 09/10/2023 | Cell & Gene Meeting on the Mesa Conference |
| 09/10/2023 | JonesTrading Healthcare Summit |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -90,9 -90,5 -0.41% | -123 -130 5.71% | -126 |
|
EBIT Million USD | Released Forecast Spread | -10,4 | -43,4 -46,6 6.87% | -69,0 -70,7 2.33% | -93,4 -93,8 0.35% | -126 -133 5.39% | -109 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,3 -40,3 -7.42% | -68,9 -70,8 2.7% | -92,1 -93,3 1.33% | -118 -126 6.82% | -102 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -49,3 -40,3 -22.1% | -70,1 -71,5 1.88% | -92,1 -93,3 1.33% | -118 -126 6.82% | -102 |
|
EPS USD | Released Forecast Spread | -110 | -231 -21,7 -961.31% | -2,10 -2,42 13.07% | -2,33 -2,34 0.41% | -1,75 -1,88 7.08% | -1,39 |
| Announcement Date | 06/11/20 | 25/03/21 | 14/03/22 | 23/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,3 -20,1 8.95% | -22,8 -19,8 -15.19% | -21,8 -24,8 11.96% | -24,1 -22,5 -7.17% | -24,7 -25,1 1.56% | -30,4 -26,8 -13.48% | -32,2 -30,0 -7.08% | -35,3 -32,7 -8.04% | -28,1 -35,4 20.66% | -27,4 | -27,3 | -27,5 | -27,9 | -26,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,3 -20,1 9.08% | -22,7 -20,0 -13.47% | -21,7 -24,7 12.39% | -23,8 -22,2 -6.93% | -23,9 -25,0 4.53% | -28,4 -25,5 -11.37% | -30,0 -28,0 -6.92% | -33,2 -31,0 -7.02% | -26,3 -34,0 22.85% | -25,8 | -25,3 | -25,4 | -25,5 | -25,4 |
|
Net income Million USD | Released Forecast Spread | -18,3 -20,1 9.08% | -22,7 -20,0 -13.47% | -21,7 -24,7 12.39% | -23,8 -22,2 -6.93% | -23,9 -25,0 4.53% | -28,4 -25,5 -11.37% | -30,0 -28,0 -6.92% | -33,2 -31,0 -7.02% | -26,3 -34,0 22.85% | -25,8 | -25,3 | -25,4 | -25,5 | -25,4 |
|
EPS USD | Released Forecast Spread | -0,49 -0,57 13.36% | -0,61 -0,51 -18.56% | -0,58 -0,66 12.08% | -0,63 -0,60 -5.08% | -0,53 -0,61 13.38% | -0,43 -0,38 -13.54% | -0,45 -0,42 -5.99% | -0,49 -0,47 -5.15% | -0,39 -0,50 22.13% | -0,37 | -0,35 | -0,35 | -0,33 | -0,31 |
| Announcement Date | 14/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 07/11/23 | 20/03/24 | - | - | - | - | - |
More events
Past sector events for Vor Biopharma Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VOR Stock
- Calendar Vor Biopharma Inc.
